0.00Open0.00Pre Close0 Volume0 Open Interest70.00Strike Price0.00Turnover6224.00%IV32.63%PremiumJun 28, 2024Expiry Date0.00Intrinsic Value100Multiplier-2DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.1016Delta0.0047Gamma48.78Leverage Ratio-269.0877Theta0.0000Rho-4.96Eff Leverage0.0011Vega
Abbott Laboratories Stock Discussion
Gapping up
$United Airlines(UAL.US)$ stock rose 5.2% after the carrier forecast stronger-than-expected earnings in the current quarter and reported a narrower-than-expected loss in the first quarter, buoyed by robust demand for travel.
$Abbott Laboratories(ABT.US)$ stock increased by 1.6% after the company surpassed quarterly profit expectations and raised the lower end of its earnings forecast, with strong dem...
Introduction
On April 17th, before the US stock market opened, Abbott (NYSE: ABT) will hold a conference call to announce its financial results for the first quarter of 2024. As a global leader in healthcare, Abbott's performance has been steadily improving in recent years, especially benefiting from the COVID-19 pandemic. According to Bloomberg data, the follow...
Read more here: Abbott Shares Slip as First-Quarter Earnings Outlook Misses Estimates
Gapping up
$Netflix(NFLX.US)$ stock rose 9.4% after the streaming giant reported the addition of far more paying subscribers in the fourth quarter than expected, helped by a slate of popular programming.
$Tesla(TSLA.US)$ stock rose 1.3% after the EV manufacturer following a Reuters report which stated the company has informed suppliers it wants to start production of a new mass-market electric vehicle in mid-2025...
No comment yet